TRADING UPDATES: Ondine hails Steriwave data; Creightons name change
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
| Price | 12.50p on 28-04-2026 at 18:40:08 |
|---|---|
| Change | 0.00p 0% |
| Buy | 13.00p |
| Sell | 12.00p |
| Last Trade: | Buy 10,000.00 at 13.00p |
| Day's Volume: | 63,117 |
| Last Close: | 12.50p |
| Open: | 12.50p |
| ISIN: | CA68234M2058 |
| Day's Range | 12.50p - 12.50p |
| 52wk Range: | 8.00p - 18.25p |
| Market Capitalisation: | £64.94m |
| VWAP: | 12.73016p |
| Shares in Issue: | 519.55m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Ondine Biomed (OBI) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 10,000 | 13.00p | Ordinary |
14:07:38 - 28-Apr-26 |
| Buy* | 3,000 | 13.00p | Ordinary |
14:07:20 - 28-Apr-26 |
| Buy* | 5,079 | 12.60p | Suspected BUY Trade |
12:42:02 - 28-Apr-26 |
| Buy* | 40,000 | 12.625p | Ordinary |
09:36:41 - 28-Apr-26 |
| Buy* | 38 | 13.00p | Ordinary |
09:31:08 - 28-Apr-26 |
| Buy* | 1,384 | 13.00p | Ordinary |
11:18:16 - 27-Apr-26 |
| Buy* | 12,000 | 13.00p | Ordinary |
09:38:50 - 27-Apr-26 |
| Sell* | 50,000 | 12.151p | Ordinary |
08:50:29 - 27-Apr-26 |
| Buy* | 8 | 13.00p | Ordinary |
08:39:11 - 27-Apr-26 |
| Buy* | 27,683 | 12.625p | Ordinary |
12:42:31 - 24-Apr-26 |
Ondine Biomed (OBI) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 28th Apr 2026 5:26 pm | RNS | Proposed c.£5 million (C$9.23 million) Fundraise |
| 27th Apr 2026 7:00 am | RNS-R | ICU Study to be Presented at 2026 CACCN Conference |
| 23rd Apr 2026 7:00 am | RNS | Marked Reduction in SSIs at Ottawa Heart Institute |
| 22nd Apr 2026 7:00 am | RNS-R | Two Abstracts Accepted at World Congress |
| 14th Apr 2026 7:00 am | RNS | Steriwave ICU Study Shows 39.5% Pneumonia Drop |
| 13th Apr 2026 7:00 am | RNS | Business Update |
| 8th Apr 2026 7:08 am | RNS-R | ICU Study Accepted for Publication |
| 24th Mar 2026 4:28 pm | RNS | Holdings in Company |
| 10th Mar 2026 7:00 am | RNS | Ondine Provides Update on US Phase 3 Pivotal Study |
| 3rd Mar 2026 7:00 am | RNS | Holdings in Company |